Catalyst Wire Dossier Catalyst Wire Dossier

liraglutide (Saxenda) 3 mg

liraglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for liraglutide (Saxenda) 3 mg, covering 2018-05-23 to 2018-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg [NA]

See pricing